【产品手册】葛兰素史克GSK_公司宣传册Brochure_Respiratory_市场营销策划_世界.docx

GSK Respiratory Committed to a brighter future for people with respiratory disease Mission Contents Committed to respiratory research development05 Committed to respiratory research development 05 A history of treatment advancement 06 Leadership Medicines Professional Community Healthcare Heritage Patients Initiative Partnerships Recognising needs09Spearheading Recognising needs 09 Spearheading landmark clinical trials 10 Social responsibility Continuous innovation in respiratory inhalers12 Continuous innovation in respiratory inhalers 12 Supporting patients and healthcare professionals 14 Responsible Contribution Leaders Development Foundation Therapy Important Research Support Sust ainabilit y Innovation First Impact Access Changing the way we work with you16 Changing the way we work with you 16 On a mission to make a difference 18 2 3 ￡3.5 billion invested in RD each year to explore new areas of scientific research and maximise the benefits we can pass on to patients with respiratory disease. Ranked No.1 in the Access to Medicines Index – an independent barometer of pharmaceutical companies’ efforts to make their products accessible and affordable to people in developing countries. million deaths are caused by respiratory disease each year. That’s why we are committed to innovation and science.2 Over 40 years of investment in respiratory research – developing medicines that have transformed the treatment of respiratory disease. We We provide around one third of medicines used by patients with asthma and COPD worldwide1 4 Committed to respiratory research development As an organisation, GSK’s mission is to improve the quality of human life by enabling patients to do more, feel better and live longer. We place the patient at the heart of everything we do and as leaders in respiratory disease we are committed to improving the lives of those living with asthma, COPD and other respiratory-related illnesses such as pulmonary arterial hypertension